Capital Equilibrium Launches a New Level-Funded Pharmacy Benefit Program Powered by Capital Rx
Capital Rx, Judi Health’s transparent pharmacy benefit management (PBM) line of business, is powering a new level-funded product, Capital Equilibrium. Unlike legacy level-funded products, Capital Equilibrium leverages Capital Rx’s full pass-through model, clinical programs, and contact center for member care – all powered by modern enterprise health technology (Judi®) – to offer clients a combination of cost savings, flexibility, and budgeting security.
Capital Rx and 3 Axis Advisors Study Finds Potential for Billions in Prescription Drug Savings With Transparent Pricing Practices
Capital Rx, the fastest-growing pharmacy benefit manager in the U.S., announced today the results of a study that it commissioned with 3 Axis Advisors, which found that implementing transparent pricing practices via the National Average Drug Acquisition Cost (NADAC) benchmark has the potential to create billions of dollars in savings, and restore public trust in the U.S. drug pricing system. The full study results are available here.
Capital Rx Named Winner of 2021 Edison Award
Capital Rx, the fastest-growing pharmacy benefit manager (PBM) in the U.S., announced today that its Clearinghouse ModelTM pricing framework has won a 2021 silver Edison Award. Named after Thomas Alva Edison, the Edison Awards have recognized and honored some of the most innovative new products, services, and business leaders in the world since 1987.
